← FDA Drug Approvals (Drugs@FDA)
ERYPAR
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PARKE DAVIS · Approved 1977-08-24
Drug application
- FDA Application #
ANDA062032
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ERYPAR
- Generic name
- Erythromycin Stearate
- Active ingredients
- ERYTHROMYCIN STEARATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- PARKE DAVIS
- First approval
- 1977-08-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown